Mestanolone
Suppliers
Names
[ CAS No. ]:
521-11-9
[ Name ]:
Mestanolone
[Synonym ]:
17a-Methylandrostan-17b-ol-3-one
Anabo
Tantaron
17b-Hydroxy-17-methyl-5a-androstan-3-one
17a-Methylandrostan-3-on-17b-ol
EINECS 208-302-6
5α-Androstan-3-one, 17β-hydroxy-17-methyl-
Assimil
Preroide
Androstan-3-one, 17-hydroxy-17-methyl-, (5α,17β)-
17a-Methylandrostanolone
17β-Hydroxy-17-methyl-5α-androstan-3-one
Antalone
mestanolone
(5α,17β)-17-Hydroxy-17-methylandrostan-3-one
17β-Hydroxy-17α-methyl-5α-androstan-3-one
Methybol
Andoron
(5S,8R,9S,10S,13S,14S,17S)-17-Hydroxy-10,13,17-trimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one
Duramin
Mestanolone (JAN)
17α-Methyl-17β-hydroxy-5α-androstan-3-one
Prohormo
(5a,17b)-17-Hydroxy-17-methylandrostan-3-one
MFCD00021158
17α-Methylandrostan-17β-ol-3-one
17α-Methyldihydrotestosterone
Chemical & Physical Properties
[ Density]:
1.1±0.1 g/cm3
[ Boiling Point ]:
416.1±38.0 °C at 760 mmHg
[ Melting Point ]:
191 °C
[ Molecular Formula ]:
C20H32O2
[ Molecular Weight ]:
304.467
[ Flash Point ]:
177.6±19.4 °C
[ Exact Mass ]:
304.240234
[ PSA ]:
37.30000
[ LogP ]:
4.29
[ Vapour Pressure ]:
0.0±2.2 mmHg at 25°C
[ Index of Refraction ]:
1.528
[ Storage condition ]:
Controlled Substance, -20?C Freezer
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- BV8064500
- CHEMICAL NAME :
- 5-alpha-Androstan-3-one, 17-beta-hydroxy-17-methyl-
- CAS REGISTRY NUMBER :
- 521-11-9
- BEILSTEIN REFERENCE NO. :
- 3207223
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 7
- MOLECULAR FORMULA :
- C20-H32-O2
- MOLECULAR WEIGHT :
- 304.52
- WISWESSER LINE NOTATION :
- L E5 B666 OVTJ A1 E1 FQ F1
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >3 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,817,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >2 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,817,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >5 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,817,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >3 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,817,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 1240 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,817,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >5 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,817,1982 ** REPRODUCTIVE DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- DOSE :
- 160 mg/kg
- SEX/DURATION :
- female 14-21 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - urogenital system
- REFERENCE :
- ENDOAO Endocrinology (Baltimore). (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- Volume(issue)/page/year: 94,979,1974
Safety Information
[ Symbol ]:
GHS08
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H351
[ Precautionary Statements ]:
P281
[ Personal Protective Equipment ]:
Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
[ Hazard Codes ]:
Xn
[ Risk Phrases ]:
R40
[ Safety Phrases ]:
S22-S36
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
BV8064500
[ HS Code ]:
2937290017
Synthetic Route
Customs
[ HS Code ]: 2937290017
Articles
J. Med. Chem. 51 , 2047-56, (2008)
A benchmark data set of steroids with known affinity for sex hormone-binding globulin (SHBG) has been widely used to validate popular molecular field-based QSAR techniques. We have expanded the data s...
Chem. Pharm. Bull. 37(7) , 1855-8, (1989)
The inhibitory effect of an anabolic steroid, stanozolol, on testicular microsomal cytochrome P-450 (17 alpha-hydroxylase/C17,20-lyase) (P-450(17 alpha/lyase] and the nature of the interaction were co...
Bioorg. Med. Chem. 16 , 6448-59, (2008)
Predictive quantitative structure-activity relationship (QSAR) models of anabolic and androgenic activities for the testosterone and dihydrotestosterone steroid analogues were obtained by means of mul...